🇺🇸 FDA
Patent

US 11517606

Composition having anti-glycation effect and application thereof

granted A61KA61K2800/70A61K36/185

Quick answer

US patent 11517606 (Composition having anti-glycation effect and application thereof) held by INFINITUS (CHINA) COMPANY LTD. expires Mon Dec 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
INFINITUS (CHINA) COMPANY LTD.
Grant date
Tue Dec 06 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K2800/70, A61K36/185, A61K36/32, A61K36/61